These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 10217622)
21. Fatty acid oxidation in peripheral blood cells: characterization and use for the diagnosis of defects of fatty acid oxidation. Schaefer J; Pourfarzam M; Bartlett K; Jackson S; Turnbull DM Pediatr Res; 1995 Mar; 37(3):354-60. PubMed ID: 7784145 [TBL] [Abstract][Full Text] [Related]
23. [Determination of normal acylcarnitine levels in a healthy pediatric population as a diagnostic tool in inherited errors of mitochondrial fatty acid beta-oxidation]. Osorio JH; Pourfarzam M An Pediatr (Barc); 2007 Dec; 67(6):548-52. PubMed ID: 18053519 [TBL] [Abstract][Full Text] [Related]
24. Analysis of organic acids after incubation with (16-2H3)palmitic acid in fibroblasts from patients with mitochondrial beta-oxidation defects. Osorio JH; Lluch M; Ribes A J Inherit Metab Dis; 2003; 26(8):795-803. PubMed ID: 14739684 [TBL] [Abstract][Full Text] [Related]
25. Production and release of acylcarnitines by primary myotubes reflect the differences in fasting fat oxidation of the donors. Wolf M; Chen S; Zhao X; Scheler M; Irmler M; Staiger H; Beckers J; de Angelis MH; Fritsche A; Häring HU; Schleicher ED; Xu G; Lehmann R; Weigert C J Clin Endocrinol Metab; 2013 Jun; 98(6):E1137-42. PubMed ID: 23633211 [TBL] [Abstract][Full Text] [Related]
26. Evidence for a short-chain carnitine-acylcarnitine translocase in mitochondria specifically related to the metabolism of branched-chain amino acids. Roe DS; Roe CR; Brivet M; Sweetman L Mol Genet Metab; 2000 Jan; 69(1):69-75. PubMed ID: 10655160 [TBL] [Abstract][Full Text] [Related]
27. [Study of plasma acylcarnitines using tandem mass spectrometry. Application to the diagnosis of metabolism hereditary diseases]. Delolme F; Vianey-Saban C; Guffon N; Favre-Bonvin J; Guibaud P; Becchi M; Mathieu M; Divry P Arch Pediatr; 1997 Sep; 4(9):819-26. PubMed ID: 9345561 [TBL] [Abstract][Full Text] [Related]
28. Measurement of plasma/serum acylcarnitines using tandem mass spectrometry. Lepage N; Aucoin S Methods Mol Biol; 2010; 603():9-25. PubMed ID: 20077055 [TBL] [Abstract][Full Text] [Related]
29. New developments in the diagnosis and investigation of mitochondrial fatty acid oxidation disorders. Coates PM Eur J Pediatr; 1994; 153(7 Suppl 1):S49-56. PubMed ID: 7957387 [TBL] [Abstract][Full Text] [Related]
31. Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation. Saudubray JM; Coudé FX; Demaugre F; Johnson C; Gibson KM; Nyhan WL Pediatr Res; 1982 Oct; 16(10):877-81. PubMed ID: 7145511 [TBL] [Abstract][Full Text] [Related]
32. Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects. Fuda F; Narayan SB; Squires RH; Bennett MJ Clin Chim Acta; 2006 May; 367(1-2):185-8. PubMed ID: 16414039 [TBL] [Abstract][Full Text] [Related]
33. The use of [9,10-3H]myristate, [9,10-3H]palmitate and [9,10-3H]oleate for the detection and diagnosis of medium and long-chain fatty acid oxidation disorders in intact cultured fibroblasts. Olpin SE; Manning NJ; Pollitt RJ; Bonham JR; Downing M; Clark S Adv Exp Med Biol; 1999; 466():321-5. PubMed ID: 10709659 [No Abstract] [Full Text] [Related]
34. Rapid diagnosis of organic acidemias and fatty-acid oxidation defects by quantitative electrospray tandem-MS acyl-carnitine analysis in plasma. Vreken P; van Lint AE; Bootsma AH; Overmars H; Wanders RJ; van Gennip AH Adv Exp Med Biol; 1999; 466():327-37. PubMed ID: 10709660 [TBL] [Abstract][Full Text] [Related]
35. Bezafibrate can be a new treatment option for mitochondrial fatty acid oxidation disorders: evaluation by in vitro probe acylcarnitine assay. Yamaguchi S; Li H; Purevsuren J; Yamada K; Furui M; Takahashi T; Mushimoto Y; Kobayashi H; Hasegawa Y; Taketani T; Fukao T; Fukuda S Mol Genet Metab; 2012 Sep; 107(1-2):87-91. PubMed ID: 22841441 [TBL] [Abstract][Full Text] [Related]
36. Choice of oils for essential fat supplements can enhance production of abnormal metabolites in fat oxidation disorders. Roe CR; Roe DS; Wallace M; Garritson B Mol Genet Metab; 2007 Dec; 92(4):346-50. PubMed ID: 17825594 [TBL] [Abstract][Full Text] [Related]
38. Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders. Shen JJ; Matern D; Millington DS; Hillman S; Feezor MD; Bennett MJ; Qumsiyeh M; Kahler SG; Chen YT; Van Hove JL J Inherit Metab Dis; 2000 Feb; 23(1):27-44. PubMed ID: 10682306 [TBL] [Abstract][Full Text] [Related]
39. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999 [TBL] [Abstract][Full Text] [Related]
40. A comparison of in vitro acylcarnitine profiling methods for the diagnosis of classical and variant short chain acyl-CoA dehydrogenase deficiency. Young SP; Matern D; Gregersen N; Stevens RD; Bali D; Liu HM; Koeberl DD; Millington DS Clin Chim Acta; 2003 Nov; 337(1-2):103-13. PubMed ID: 14568186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]